ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987

ACS announces 415 New Awards

August 31, 1979

News Analysis: Legislation on Drug Shortage Crisis Moves Toward Passage on Capitol Hill

June 22, 2012

In Brief: Five Institutions To Test Interferon; Appendectomy-Cancer Association Noted

October 27, 1978

(8-page issue).

January 31, 2003